Skip to main content
. 2021 Oct 23;13(2):517–540. doi: 10.1016/j.jcmgh.2021.10.008

Table 3.

Results of Gene Set Enrichment Analysis on CT–PDTO Vs PDTO Gene Expression Signatures

Tumor organoid line (chemotolerant vs ctrl) Hallmark NES NOM P value
PDTO1 HALLMARK_ANGIOGENESIS 1.583 .032
HALLMARK_COAGULATION 1.524 .035
HALLMARK_COMPLEMENT 1.357 .055
HALLMARK_INTERFERON_ALPHA_RESPONSE 1.406 .056
PDTO2 HALLMARK_MYC_TARGETS_V1 2.178 .000
HALLMARK_E2F_TARGETS 1.924 .000
HALLMARK_MYC_TARGETS_V2 1.886 .000
HALLMARK_INTERFERON_ALPHA_RESPONSE 1.447 .028
HALLMARK_G2M_CHECKPOINT 1.238 .059
PDTO5 HALLMARK_E2F_TARGETS 2.103 .000
HALLMARK_G2M_CHECKPOINT 1.856 .000
HALLMARK_MYC_TARGETS_V1 1.697 .000
HALLMARK_MYC_TARGETS_V2 1.481 .037

NOTE. The gene sets that are enriched after acquisition of chemotolerance are shown.

NES, normalized enrichment score; NOM P value, nominal P value.